Robert J. Cardnell

机构：The University of Texas MD Anderson Cancer Center · ORCID：0009-0005-6203-0234

发表论文 213 篇 · 总被引 3436 次 · h-index 20

代表论文

• YAP1 Status Defines Two Intrinsic Subtypes of LCNEC with Distinct Molecular Features and Therapeutic Vulnerabilities (2024 · Clinical Cancer Research · 被引 20)
• Brief Report: Comprehensive Clinicogenomic Profiling of Small Cell Transformation From EGFR-Mutant NSCLC Informs Potential Therapeutic Targets (2023 · JTO Clinical and Research Reports · 被引 13)
• DNA damage response signatures are associated with frontline chemotherapy response and routes of tumor evolution in extensive stage small cell lung cancer (2025 · Molecular Cancer · 被引 8)
• Treatment monitoring by biomarker analysis in a Phase I dose-expansion study of AZD2811 for relapsed/refractory small-cell lung cancer (2026 · British Journal of Cancer · 被引 2)
• The Impact of Targeting TRAF2 and NCK-Interacting Protein Kinase on Antitumor Effect and Tumor Immune Environment in c-MYC–High SCLC (2025 · Journal of Thoracic Oncology · 被引 2)
• CyTOF-based profiling of circulating tumor cells predicts aggressiveness and therapy response in SCLC liquid biopsies at a personalized level (2025 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 2)